<p>Ruth Connor of Symbiora Inc. in the U.S. will evaluate the safety and effectiveness of a low-cost oral solution derived from beneficial strains of human gut bacteria to prevent and treat acute diarrheal illness in infants.</p>


Ruth Connor of Symbiora Inc. in the U.S. will evaluate the safety and effectiveness of a low-cost oral solution derived from beneficial strains of human gut bacteria to prevent and treat acute diarrheal illness in infants.